199 related articles for article (PubMed ID: 21390047)
1. ERCC5 p.Asp1104His and ERCC2 p.Lys751Gln polymorphisms are independent prognostic factors for the clinical course of melanoma.
Schrama D; Scherer D; Schneider M; Zapatka M; Bröcker EB; Schadendorf D; Ugurel S; Kumar R; Becker JC
J Invest Dermatol; 2011 Jun; 131(6):1280-90. PubMed ID: 21390047
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control analysis.
Li C; Hu Z; Liu Z; Wang LE; Strom SS; Gershenwald JE; Lee JE; Ross MI; Mansfield PF; Cormier JN; Prieto VG; Duvic M; Grimm EA; Wei Q
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2526-32. PubMed ID: 17164380
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms of nucleotide excision repair genes predict melanoma survival.
Li C; Yin M; Wang LE; Amos CI; Zhu D; Lee JE; Gershenwald JE; Grimm EA; Wei Q
J Invest Dermatol; 2013 Jul; 133(7):1813-21. PubMed ID: 23407396
[TBL] [Abstract][Full Text] [Related]
4. An association of selected ERCC2 and ERCC5 genes polymorphisms, the level of oxidative DNA damage and its repair efficiency with a risk of colorectal cancer in Polish population.
Kabzinski J; Przybylowska K; Dziki L; Dziki A; Majsterek I
Cancer Biomark; 2015; 15(4):413-23. PubMed ID: 25835182
[TBL] [Abstract][Full Text] [Related]
5. Laryngeal cancer risk and common single nucleotide polymorphisms in nucleotide excision repair pathway genes ERCC1, ERCC2, ERCC3, ERCC4, ERCC5 and XPA.
Lu B; Li J; Gao Q; Yu W; Yang Q; Li X
Gene; 2014 May; 542(1):64-8. PubMed ID: 24582975
[TBL] [Abstract][Full Text] [Related]
6. Lack of association between XPG Asp1104His and XPF Arg415Gln polymorphism and breast cancer risk: a meta-analysis of case-control studies.
Ding DP; He XF; Zhang Y
Breast Cancer Res Treat; 2011 Aug; 129(1):203-9. PubMed ID: 21424776
[TBL] [Abstract][Full Text] [Related]
7. Relationships between genetic polymorphisms and anticancer drug cytotoxicity vis-à-vis the NCI-60 panel.
Le Morvan V; Bellott R; Moisan F; Mathoulin-Pélissier S; Bonnet J; Robert J
Pharmacogenomics; 2006 Sep; 7(6):843-52. PubMed ID: 16981845
[TBL] [Abstract][Full Text] [Related]
8. Single nucleotide polymorphisms in nucleotide excision repair genes XPA, XPD, XPG and ERCC1 in advanced colorectal cancer patients treated with first-line oxaliplatin/fluoropyrimidine.
Monzo M; Moreno I; Navarro A; Ibeas R; Artells R; Gel B; Martinez F; Moreno J; Hernandez R; Navarro-Vigo M
Oncology; 2007; 72(5-6):364-70. PubMed ID: 18204222
[TBL] [Abstract][Full Text] [Related]
9. DNA repair genes XPC, XPG polymorphisms: relation to the risk of colorectal carcinoma and therapeutic outcome with Oxaliplatin-based adjuvant chemotherapy.
Liu D; Wu HZ; Zhang YN; Kang H; Sun MJ; Wang EH; Yang XL; Lian MQ; Yu ZJ; Zhao L; Olopade OI; Wei MJ
Mol Carcinog; 2012 Oct; 51 Suppl 1():E83-93. PubMed ID: 22213216
[TBL] [Abstract][Full Text] [Related]
10. Genetic variability of genes in NER pathway influences the treatment outcome of gastric cancer.
Xue MH; Li GY; Wu XJ; Zhang CX; Zhang CF; Zhu KX
Int J Clin Exp Pathol; 2015; 8(5):5563-9. PubMed ID: 26191265
[TBL] [Abstract][Full Text] [Related]
11. Laryngeal cancer risk associated with smoking and alcohol consumption is modified by genetic polymorphisms in ERCC5, ERCC6 and RAD23B but not by polymorphisms in five other nucleotide excision repair genes.
Abbasi R; Ramroth H; Becher H; Dietz A; Schmezer P; Popanda O
Int J Cancer; 2009 Sep; 125(6):1431-9. PubMed ID: 19444904
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in the DNA nucleotide excision repair genes and lung cancer risk in Xuan Wei, China.
Shen M; Berndt SI; Rothman N; Demarini DM; Mumford JL; He X; Bonner MR; Tian L; Yeager M; Welch R; Chanock S; Zheng T; Caporaso N; Lan Q
Int J Cancer; 2005 Sep; 116(5):768-73. PubMed ID: 15849729
[TBL] [Abstract][Full Text] [Related]
13. ERCC2 genotypes and a corresponding haplotype are linked with breast cancer risk in a German population.
Justenhoven C; Hamann U; Pesch B; Harth V; Rabstein S; Baisch C; Vollmert C; Illig T; Ko YD; Brüning T; Brauch H
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2059-64. PubMed ID: 15598761
[TBL] [Abstract][Full Text] [Related]
14. Nucleotide Excision Repair Gene ERCC2 and ERCC5 Variants Increase Risk of Uterine Cervical Cancer.
Joo J; Yoon KA; Hayashi T; Kong SY; Shin HJ; Park B; Kim YM; Hwang SH; Kim J; Shin A; Kim JY
Cancer Res Treat; 2016 Apr; 48(2):708-14. PubMed ID: 26130668
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in XPC, XPD and XPG DNA repair genes and leukemia risk in a Tunisian population.
Douzi K; Ouerhani S; Menif S; Safra I; Abbes S
Leuk Lymphoma; 2015 Jun; 56(6):1856-62. PubMed ID: 25311495
[TBL] [Abstract][Full Text] [Related]
16. ERCC polymorphisms and prognosis of patients with osteosarcoma.
Li J; Liu S; Wang W; Zhang K; Liu Z; Zhang C; Chen S; Wu S
Tumour Biol; 2014 Oct; 35(10):10129-36. PubMed ID: 25023406
[TBL] [Abstract][Full Text] [Related]
17. Association between the ERCC5 Asp1104His polymorphism and cancer risk: a meta-analysis.
Zhu ML; Wang M; Cao ZG; He J; Shi TY; Xia KQ; Qiu LX; Wei QY
PLoS One; 2012; 7(7):e36293. PubMed ID: 22815677
[TBL] [Abstract][Full Text] [Related]
18. ERCC5/XPG, ERCC1, and BRCA1 gene status and clinical benefit of trabectedin in patients with soft tissue sarcoma.
Italiano A; Laurand A; Laroche A; Casali P; Sanfilippo R; Le Cesne A; Judson I; Blay JY; Ray-Coquard I; Bui B; Coindre JM; Nieto A; Tercero JC; Jimeno J; Robert J; Pourquier P
Cancer; 2011 Aug; 117(15):3445-56. PubMed ID: 21287534
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in nucleotide excision repair genes and risk of multiple primary melanoma: the Genes Environment and Melanoma Study.
Millikan RC; Hummer A; Begg C; Player J; de Cotret AR; Winkel S; Mohrenweiser H; Thomas N; Armstrong B; Kricker A; Marrett LD; Gruber SB; Culver HA; Zanetti R; Gallagher RP; Dwyer T; Rebbeck TR; Busam K; From L; Mujumdar U; Berwick M
Carcinogenesis; 2006 Mar; 27(3):610-8. PubMed ID: 16258177
[TBL] [Abstract][Full Text] [Related]
20. The effect of tobacco, XPC, ERCC2 and ERCC5 genetic variants in bladder cancer development.
Rouissi K; Bahria IB; Bougatef K; Marrakchi R; Stambouli N; Hamdi K; Cherif M; Ben Slama MR; Sfaxi M; Othman FB; Chebil M; Elgaaied AB; Ouerhani S
BMC Cancer; 2011 Mar; 11():101. PubMed ID: 21426550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
